In this free webinar, gain insights into understanding the functional service provider (FSP) model for mid-sized companies. Attendees will learn about the strategic formulation of an FSP partnership. The featured speakers will discuss maximizing the benefits of collaborating with contract research organizations (CROs) through FSP.
TORONTO, Jan. 15, 2024 /PRNewswire-PRWeb/ -- In general, large pharmaceutical companies favor adopting functional service provider (FSP) models over full-service outsourcing across their clinical and research and development (R&D) operations.
FSPs allow for greater oversight and can offer better outcomes regarding accelerated delivery and higher quality data. For the most part, though, only large pharmaceutical companies have been positioned to take advantage of FSP models. Their organizational maturity has afforded them this competitive advantage.
But must FSP models be the exclusive domain of the largest companies? Can smaller companies benefit from working with a contract research organization (CRO) through an FSP model?
During this webinar, participants will delve into the explorative realm of FSP models, particularly how to curate them for mid-sized companies to elevate their clinical trial performance. Experts will discuss how to strategically formulate an FSP partnership, customized to meet your company's distinctive needs, ensuring a mutually beneficial collaboration that addresses and anticipates specific clinical trial demands. There will be an overview of the critical first steps and decisions in the FSP journey, including the methodology behind conducting a thorough readiness assessment, architecting a sustainable resourcing strategy and endorsing a solution that's exemplary for study requirements.
The webinar will demystify the pathway that enables smaller companies to derive palpable value and enhance their competitive stance through engaging with CROs via an adeptly implemented FSP model, opening doors to augmented oversight, optimized outcomes and a future-proofed clinical trial landscape.
Join experts from Syneos Health, Jeni Fan, Executive Director, Project Delivery, FSP360; Jennifer Sozio, Senior Vice President, Clinical Operations, FSP360; and Robert Liebman, Managing Director, Consulting, for the live webinar on Monday, February 5, 2024, at 1pm EST.
For more information, or to register for this event, visit Unlocking Superior R&D Results for Emerging BioPharmas: Mastering the FSP Model.
ABOUT SYNEOS HEALTH
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]